162 related articles for article (PubMed ID: 27822890)
1. Comparison of the endothelial coverage in everolimus and zotarolimus-eluting stents in normal, atherosclerotic, and bifurcation rabbit iliac arteries.
Torii S; Nakazawa G; Ijichi T; Yoshikawa A; Ohno Y; Ikari Y
Cardiovasc Interv Ther; 2018 Jan; 33(1):55-61. PubMed ID: 27822890
[TBL] [Abstract][Full Text] [Related]
2. Resolute and Xience V polymer-based drug-eluting stents compared in an atherosclerotic rabbit double injury model.
Van Dyck CJ; Hoymans VY; Bult H; Fransen E; Haine S; Bosmans JM; Timmermans JP; Vrints CJ
Catheter Cardiovasc Interv; 2013 Jun; 81(7):E259-68. PubMed ID: 22887820
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of second-generation everolimus- and zotarolimus-eluting coronary stents.
Yazdani SK; Sheehy A; Nakano M; Nakazawa G; Vorpahl M; Otsuka F; Donn RS; Perkins LE; Simonton CA; Kolodgie FD; Virmani R
J Invasive Cardiol; 2013 Aug; 25(8):383-90. PubMed ID: 23913602
[TBL] [Abstract][Full Text] [Related]
4. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis.
Hoymans VY; VAN Dyck CJ; Haine SE; Frederix G; Fransen E; Timmermans JP; Vrints CJ
J Interv Cardiol; 2014 Aug; 27(4):381-90. PubMed ID: 24815761
[TBL] [Abstract][Full Text] [Related]
5. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).
Kim JS; Kim BK; Jang IK; Shin DH; Ko YG; Choi D; Hong MK; Cho YK; Nam CW; Hur SH; Choi JH; Song YB; Hahn JY; Choi SH; Gwon HC; Jang Y
Am Heart J; 2012 Apr; 163(4):601-7. PubMed ID: 22520526
[TBL] [Abstract][Full Text] [Related]
6. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
[TBL] [Abstract][Full Text] [Related]
7. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerotic change at one year after implantation of Endeavor zotarolimus-eluting stent vs. everolimus-eluting stent.
Akazawa Y; Matsuo K; Ueda Y; Nishio M; Hirata A; Asai M; Nemoto T; Wada M; Murakami A; Kashiwase K; Kodama K
Circ J; 2014; 78(6):1428-36. PubMed ID: 24717233
[TBL] [Abstract][Full Text] [Related]
9. Zotarolimus-eluting Resolute Integrity versus everolimus-eluting Xience Xpedition stents in the management of very long (>30mm) de novo coronary artery stenosis.
Patra S; Chakraborty RN; Pande A; Banerjee S; Jena M; Mandal PC; De SK; Khan A; Das SS; Ghosh D; Nag R
Cardiovasc Revasc Med; 2017; 18(3):160-164. PubMed ID: 28017259
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis.
Piccolo R; Stefanini GG; Franzone A; Spitzer E; Blöchlinger S; Heg D; Jüni P; Windecker S
Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25858975
[TBL] [Abstract][Full Text] [Related]
11. Three-year patient-related and stent-related outcomes of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries).
Lee JM; Park KW; Han JK; Yang HM; Kang HJ; Koo BK; Bae JW; Woo SI; Park JS; Jin DK; Jeon DW; Oh SK; Park JS; Kim DI; Hyon MS; Jeon HK; Lim DS; Kim MG; Rha SW; Her SH; Hwang JY; Kim S; Choi YJ; Kang JH; Moon KW; Jang Y; Kim HS
Am J Cardiol; 2014 Nov; 114(9):1329-38. PubMed ID: 25217457
[TBL] [Abstract][Full Text] [Related]
12. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC
Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031
[TBL] [Abstract][Full Text] [Related]
13. Comparison of early-phase arterial repair following cobalt-chrome everolimus-eluting stent and slow-release zotarolimus-eluting stent: an angioscopic study.
Ishihara T; Iida O; Fujita M; Masuda M; Okamoto S; Nanto K; Kanda T; Tsujimura T; Sunaga A; Awata M; Nanto S; Uematsu M
Cardiovasc Interv Ther; 2018 Apr; 33(2):163-168. PubMed ID: 28255728
[TBL] [Abstract][Full Text] [Related]
14. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
15. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the performance of zotarolimus- and everolimus-eluting stents by optical coherence tomography and coronary angioscopy.
Masawa T; Abe S; Toyoda S; Sakuma M; Nasuno T; Kageyama M; Tokura M; Koizumi S; Taguchi I; Inoue T
Heart Vessels; 2016 Aug; 31(8):1230-8. PubMed ID: 26271923
[TBL] [Abstract][Full Text] [Related]
17. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study.
Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A
EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
von Birgelen C; Basalus MW; Tandjung K; van Houwelingen KG; Stoel MG; Louwerenburg JH; Linssen GC; Saïd SA; Kleijne MA; Sen H; Löwik MM; van der Palen J; Verhorst PM; de Man FH
J Am Coll Cardiol; 2012 Apr; 59(15):1350-61. PubMed ID: 22341737
[TBL] [Abstract][Full Text] [Related]
20. Comparison of angioscopic findings among second-generation drug-eluting stents.
Nishimoto Y; Ueda Y; Sugihara R; Murakami A; Ueno K; Takeda Y; Hirata A; Kashiwase K; Higuchi Y; Yasumura Y
J Cardiol; 2017 Sep; 70(3):297-302. PubMed ID: 28034576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
